Because they can be programmed to travel the body and selectively target cancer and other sites of disease, nanometer - scale vehicles
called nanocarriers can deliver higher concentrations of drugs to bombard specific areas...
Now, a multidisciplinary research team led by David Eckmann, MD, PhD, Horatio C. Wood Professor of Anesthesiology and Critical Care at the Perelman School of Medicine at the University of Pennsylvania and professor of Bioengineering in Penn's School of Engineering and Applied Science, has found that when delivered by a microscopic transporter
called a nanocarrier, steroids can access the hard - to - reach lung endothelial cells that need it most and are successful at preventing inflammation in mice.
Berkeley Lab researchers have developed a new family of
nanocarriers,
called «3HM,» that meets all the size and stability requirements for effectively delivering therapeutic drugs to the brain for the treatment of a deadly form of cancer known as glioblastoma multiforme.